Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.749 USD | -1.45% | -10.02% | -40.40% |
Apr. 15 | Biomerica Provides Update on inFoods IBS Expansion | CI |
Apr. 12 | Biomerica, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended February 29, 2024 | CI |
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Clinical Lab
62.0
%
| 3 | 16.2 % | 3 | 62.0 % | +8.03% |
Over-the-counter
21.9
%
| 1 | 5.8 % | 1 | 21.9 % | +7.35% |
Contract Manufacturing
11.4
%
| 0 | 2.4 % | 1 | 11.4 % | +32.90% |
Physicians' Office
4.7
%
| 14 | 75.6 % | 0 | 4.7 % | -98.25% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Asia
37.9
%
| 13 | 70.9 % | 2 | 37.9 % | -84.89% |
Europe
33.7
%
| 4 | 23.0 % | 2 | 33.7 % | -58.56% |
North America
27.5
%
| 1 | 5.3 % | 1 | 27.5 % | +47.44% |
Middle East
0.7
%
| 0 | 0.4 % | 0 | 0.7 % | -44.29% |
South America
0.2
%
| 0 | 0.5 % | 0 | 0.2 % | -87.78% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Zackary Irani
CEO | Chief Executive Officer | 58 | 85-12-31 |
Gary Lu
DFI | Director of Finance/CFO | 43 | 23-02-28 |
Robert Carlson
PRN | Corporate Officer/Principal | - | 22-08-29 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Zackary Irani
CEO | Chief Executive Officer | 58 | 85-12-31 |
Allen Barbieri
BRD | Director/Board Member | 65 | 99-09-30 |
Jane Emerson
BRD | Director/Board Member | 70 | 07-03-31 |
David Moatazedi
BRD | Director/Board Member | 46 | 22-12-06 |
John Kenny
CHM | Chairman | 54 | 23-08-24 |
Catherine Coste
BRD | Director/Board Member | 58 | 20-09-02 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 16,821,646 | 15,592,969 ( 92.70 %) | 0 | 92.70 % |
Company contact information
Sector
Sales per Business
Sales per region
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-40.40% | 12.78M | |
-2.79% | 183B | |
-3.69% | 105B | |
+5.51% | 51.77B | |
+16.61% | 47.29B | |
-1.73% | 40.2B | |
+6.58% | 27.62B | |
-1.67% | 25.51B | |
+9.84% | 24.73B | |
-2.01% | 24.52B |
- Stock Market
- Equities
- BMRA Stock
- Company Biomerica, Inc.